Shiley Settlement Reviewed by Judge
- Share via
A federal judge on Friday took under consideration a proposal to establish a $205-million fund to compensate recipients of potentially defective Shiley heart valves.
Attorneys for Shiley Inc., the Irvine-based manufacturer of the device, and its parent company, Pfizer Inc. in New York, outlined the offer before U.S. District Judge S. Arthur Spiegel in Cincinnati to pay $75 million toward research and valve replacement surgery and an additional $80 million to $130 million to pay for physician consultations and anxiety-related medical expenses.
Shiley would also set aside $300 million more for future patient or survivor claims. The company estimates there are nearly 55,000 valve recipients worldwide.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
